newsfilter
← Latest News
PR Newswire·

Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development

VEEV
  • More than 175 emerging biotechs are adopting Veeva Basics to establish a technology foundation for streamlined operations.
  • The pre-configured & pre-validated applications enable biotechs to launch systems in weeks that scale from startup to commercialization.
  • Veeva Basics provides unified, end-to-end solutions for clinical, regulatory, quality, medical, & commercial functions to reduce time, effort, & cost.
  • Whitehawk Therapeutics replaced paper processes with Veeva Basics to improve regulatory & quality compliance without requiring an IT team.
  • Structure Therapeutics shifted submission publishing from outsourced to insourced using Veeva Submissions Publishing Basics for faster timelines & better quality control.
  • The platform allows biotechs preparing for FDA submissions to gain improved visibility & control across the entire regulatory lifecycle.
  • Veeva Basics is built on the Vault Platform to allow seamless scaling of technology infrastructure as companies grow.
  • Veeva Systems serves over 1,500 customers ranging from large pharmaceutical companies to emerging biotechs.
  • The company invites life sciences professionals to register for the Veeva R&D and Quality Summit taking place Oct. 20-21 in Boston.
  • The press release includes standard forward-looking statements & references to risk factors disclosed in SEC filings.